These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23682005)

  • 41. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine.
    Uzicanin A; Thompson M; Smith P; Chaves SS; Foster L; Dube N; Graitcer S; Jackson R; Ferdinands J; Gargiullo P; Mills D; Monto AS; Shay DK;
    J Infect Dis; 2012 Oct; 206(7):1059-68. PubMed ID: 22850120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients.
    Cherif H; Höglund M; Pauksens K
    Eur J Haematol; 2013 May; 90(5):413-9. PubMed ID: 23444982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy.
    Shahgholi E; Ehsani MA; Salamati P; Maysamie A; Sotoudeh K; Mokhtariazad T
    Pediatr Blood Cancer; 2010 May; 54(5):716-20. PubMed ID: 20205258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A; Willén L; Grödeberg L; Skattum L; Hagberg H; Pauksens K
    Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
    Zhan Y; Yang Z; Li L; Ye D; Wu H; Fu R; Zhao S; Wang Y; Zhou R; Chen R
    Jpn J Infect Dis; 2011; 64(3):190-4. PubMed ID: 21617301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.
    Mathian A; Devilliers H; Krivine A; Costedoat-Chalumeau N; Haroche J; Huong DB; Wechsler B; Hervier B; Miyara M; Morel N; Le Corre N; Arnaud L; Piette JC; Musset L; Autran B; Rozenberg F; Amoura Z
    Arthritis Rheum; 2011 Nov; 63(11):3502-11. PubMed ID: 21811996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation.
    Gueller S; Allwinn R; Mousset S; Martin H; Wieters I; Herrmann E; Serve H; Bickel M; Bug G
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1546-50. PubMed ID: 21324375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Lertdumrongluk P; Changsirikulchai S; Limkunakul C; Prachukthum P; Punpiput P; Buppanharun R; Chotpitayasunondh C
    Vaccine; 2012 Feb; 30(6):1108-14. PubMed ID: 22178515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.
    Stowe J; Andrews N; Bryan P; Seabroke S; Miller E
    Vaccine; 2011 Nov; 29(51):9467-72. PubMed ID: 22019757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
    Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom.
    Bate J; Yung CF; Hoschler K; Sheasby L; Morden J; Taj M; Heath PT; Miller E
    Clin Infect Dis; 2010 Dec; 51(12):e95-104. PubMed ID: 21067352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors associated with receipt of 2009 pandemic influenza A (H1N1) monovalent and seasonal influenza vaccination among school-aged children: Maricopa County, Arizona, 2009-2010 influenza season.
    Baty SA; Ayala A; Odish M; Cadwell BL; Schumacher M; Sunenshine RH
    J Public Health Manag Pract; 2013; 19(5):436-43. PubMed ID: 23549371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
    Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
    Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients.
    Labriola L; Hombrouck A; Maréchal C; Van Gucht S; Brochier B; Thomas I; Jadoul M; Goubau P
    Nephrol Dial Transplant; 2011 Apr; 26(4):1424-8. PubMed ID: 21273236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
    Azevedo LS; Gerhard J; Miraglia JL; Precioso AR; Tavares Timenetsky MD; Agena F; Gamba C; Shikanai Yasuda MA; David-Neto E; Pierrotti L
    Transpl Infect Dis; 2013 Dec; 15(6):612-8. PubMed ID: 24134688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults.
    Cooper C; Klein M; Walmsley S; Haase D; MacKinnon-Cameron D; Marty K; Li Y; Smith B; Halperin S; Law B; Scheifele D;
    HIV Clin Trials; 2012; 13(1):23-32. PubMed ID: 22306585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study.
    Lindsey BB; Jagne YJ; Armitage EP; Singanayagam A; Sallah HJ; Drammeh S; Senghore E; Mohammed NI; Jeffries D; Höschler K; Tregoning JS; Meijer A; Clarke E; Dong T; Barclay W; Kampmann B; de Silva TI
    Lancet Respir Med; 2019 Aug; 7(8):665-676. PubMed ID: 31235405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of aluminum hydroxide adjuvant on the immunogenicity of the 2009 pandemic influenza A/H1N1 vaccine: multi-level modeling of data with repeated measures.
    Yin DP; Zhu BP; Wang HQ; Cao L; Wu WD; Jiang KY; Xia W; Zhang GM; Zheng JS; Cao LS; Liang XF
    Biomed Environ Sci; 2011 Dec; 24(6):624-9. PubMed ID: 22365398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effects of influenza A (H1N1) pandemic 2009 vaccination against the onset of influenza-like illness and asthma exacerbation in Japanese children.
    Yokouchi Y; Katsumori H; Shirakawa S; Fujiwara M; Kashima K; Kozawa R; Koike Y
    J Asthma; 2014 Oct; 51(8):825-31. PubMed ID: 24739075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine.
    Busse WW; Peters SP; Fenton MJ; Mitchell H; Bleecker ER; Castro M; Wenzel S; Erzurum SC; Fitzpatrick AM; Teague WG; Jarjour N; Moore WC; Sumino K; Simeone S; Ratanamaneechat S; Penugonda M; Gaston B; Ross TM; Sigelman S; Schiepan JR; Zaccaro DJ; Crevar CJ; Carter DM; Togias A
    J Allergy Clin Immunol; 2011 Jan; 127(1):130-7, 137.e1-3. PubMed ID: 21145578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.